IRIS
CERONI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.821
AS - Asia 6.370
EU - Europa 6.274
SA - Sud America 611
AF - Africa 74
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.656
CN - Cina 3.812
IE - Irlanda 1.425
SG - Singapore 1.353
UA - Ucraina 1.073
FI - Finlandia 793
DE - Germania 790
HK - Hong Kong 692
RU - Federazione Russa 603
SE - Svezia 576
BR - Brasile 501
GB - Regno Unito 344
IT - Italia 341
VN - Vietnam 183
FR - Francia 128
CA - Canada 105
IN - India 87
AR - Argentina 47
JP - Giappone 40
MX - Messico 39
BD - Bangladesh 34
ZA - Sudafrica 32
PL - Polonia 31
BE - Belgio 29
NL - Olanda 26
ES - Italia 24
IQ - Iraq 23
AT - Austria 22
EC - Ecuador 18
TR - Turchia 18
CZ - Repubblica Ceca 15
AU - Australia 13
ID - Indonesia 13
PK - Pakistan 13
VE - Venezuela 11
LT - Lituania 10
IR - Iran 9
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
IL - Israele 8
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
MA - Marocco 7
AZ - Azerbaigian 6
CL - Cile 6
LV - Lettonia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
PE - Perù 5
TW - Taiwan 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
AL - Albania 3
BO - Bolivia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
KR - Corea 3
LU - Lussemburgo 3
NI - Nicaragua 3
PH - Filippine 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GI - Gibilterra 2
GT - Guatemala 2
GY - Guiana 2
MY - Malesia 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
Totale 22.156
Salva come PNG Salva come JPEG
Città #
Chandler 1.477
Dublin 1.420
Jacksonville 1.227
Nanjing 935
Hong Kong 688
Ashburn 666
Dallas 666
Singapore 615
Boardman 494
Beijing 492
Nanchang 358
Princeton 284
Lawrence 276
Shenyang 268
Hebei 264
Wilmington 260
Changsha 237
Helsinki 237
Jiaxing 233
Los Angeles 213
Medford 193
Ann Arbor 184
Munich 164
Hangzhou 156
Buffalo 153
Tianjin 149
New York 130
Moscow 128
Shanghai 101
Woodbridge 95
Milan 88
Redondo Beach 68
Ho Chi Minh City 66
Pavia 60
São Paulo 59
Turku 58
Verona 54
Norwalk 53
Falkenstein 50
Dearborn 49
Toronto 43
Seattle 41
Hanoi 39
Houston 38
Santa Clara 37
Tokyo 36
Zhengzhou 31
Chicago 30
San Francisco 30
Brussels 29
Montreal 29
Fairfield 28
Kunming 28
Brooklyn 27
Stockholm 27
The Dalles 26
Boston 25
Warsaw 25
Des Moines 24
Jinan 23
Rome 23
Guangzhou 21
Nuremberg 21
Orem 21
Pune 21
Atlanta 20
Johannesburg 20
London 20
Chennai 18
Falls Church 18
Auburn Hills 17
Poplar 17
Denver 16
Council Bluffs 14
Ningbo 14
Phoenix 14
Rio de Janeiro 14
San Jose 13
Changchun 12
Vienna 12
Washington 12
Belo Horizonte 11
Curitiba 11
Haiphong 11
Manchester 11
Borås 10
Hefei 10
Mumbai 10
Ottawa 10
Columbus 9
Frankfurt am Main 9
Fuzhou 9
Mexico City 9
Redwood City 9
Guarulhos 8
Rockville 8
Shenzhen 8
Amman 7
Brasília 7
Brno 7
Totale 14.516
Salva come PNG Salva come JPEG
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 145
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation 134
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 133
2-DE AND MALDI-TOF-MS FOR A COMPARATIVE ANALYSIS OF PROTEINS EXPRESSED IN DIFFERENT CELLULAR MODELS OF AMYOTROPHIC LATERAL SCLEROSIS 128
Immunocytochemical detection of the Interleukin-2 receptors a and b on cell surface of normal and pathological cells. 127
Activated lymphocytes in glioblastoma: significance for anti-tumoral immunity 127
A Randomized Phase III study: Comparison between Intra-venous and Intra-arterial ACNU Administration in Newly Diagnosed Primary Glioblastomas. 125
Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation 124
Autofluorescence-assisted delineation of glioblastoma resection margins. 122
Analysis immunohistochemical of the HLA class I molecules in human glioma. 122
Acute disseminated encephalomyelitis: Clinical, biological, neurophysiological and radiological prognostic markers 122
Analysis of HLA antigen expression in formalin-fixed, paraffin-embedded astrocytic tumours. 121
ISOLATION OF GENETIC MARKERS FROM HUMAN GLIOBLASTOMA CELLS BY DIFFERENTIAL DISPLAY TECHNIQUE 120
Meningeal melanomatosis: a challenge for timely diagnosis. 119
Balance between proliferation and cell death in 8 selected supratentorial pilocytic astrocytomas. 117
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation. 117
Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication 117
Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes 116
Detection of a novel antineuronal antibody in paraneoplastic brainstem encephalitis. 114
Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia. 114
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 111
A prospective cohort study in JCV and non JCV-related leukoencephalopathies in HIV patients 111
Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence. 110
Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence 110
Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression. 110
Autofluorescence-based real time diagnosis for selective resection of tumors in neurosurgery. 110
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 110
Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma 109
Analysis of HLA class I antigen and antigen-processing machinery components in human brain tumours. 109
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 108
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 107
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 107
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation 106
Immunohistochemical and in situ hybridization localization of doppel protein as a new marker astrocytic tumour progression. 106
Trauma and amyotrophic lateral sclerosis: A case-control study from a population-based registry 105
Early cortical and late striatal diffusion restriction on 3T MRI in long-lived sporadic Creutzfeldt-Jakob disease case. 105
Immunohistochemical expression of HLA antigens and components of the antigen processing machinery in astrocytic tumors. 104
Acute Disseminated Encephalomyelitis (ADEM): A Prospective Study on 122 Adults 104
About the original description of cerebellar tonsil herniation by Pierre Marie. 104
Postinfectious neurologic syndromes: A prospective cohort study 103
Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS 103
A novel compound heterozygous mutation of C20orf54 gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family 103
Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients 102
Activity of protein phosphatase calcineurin in decreased in sporadic and familiar amyotrophic lateral sclerosis patients. 101
Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma. 101
Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients. 101
Severe recurrent myelitis in patients with hepatitis C virus infection 100
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 100
Comparison of different immunohistochemical techniques for detection of anti-neuronal specific antibodies. 99
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 99
Immunohistochemistry and in situ hybridization of “Doppel protein” in human astrocytic tumours 99
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 99
Experimental diets for the prevention of the development of familial amyotrophic lateral sclerosis 98
Immunohistochemical analysis to estimate actively proliferating, competent to proliferate and differentiated cell subsets in astrocytic tumours. 98
Heterogeneous distribution of amyotrophic lateral sclerosis patient with SOD-1 gene mulations: preliminary data on an Italian survey 97
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 97
Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories 96
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 96
Doppel protein as a new marker in astrocytic tumour progression 95
Lateral gaze synkinesis on downward saccade attempts with paramedian thalamic and midbrain infarct 95
Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins 94
Study of HLA class I antigen and antigen-processing machinery components in human glioblastoma. 93
Experimental diets for the prevention of the development of familial amyotrophic lateral sclerosis 93
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 93
Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients 93
Leukocite derived microvescicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis. 93
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 93
Interleukin-2 induces the growth of human glioblastoma cells in culture. 92
Severe recurrent myelitis in patients with hepatitis C virus infection patients 92
Cerebrospinal fluid ferritin in human disease. 91
Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan 90
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis 90
Amyotrophic lateral sclerosis and SOD1 gene: an overview 90
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 90
Myelin basic protein purification in non denaturing conditions. 89
Clinical and MRI logitudinal study in two case-reports of long-lasting sCJD patients 89
Mini Nutritional Assessment May Identify a Dual Pattern of Perturbed Plasma Amino Acids in Patients with Alzheimer's Disease: A Window to Metabolic and Physical Rehabilitation? 89
Study in vitro of the effect of ACNU, carboplatin and etoposide on LAK cells. 88
Combined central and peripheral demyelination: comparison of adult and pediatric series 88
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS 88
Doppel protein as a new marker in astrocytic tumour progression. 88
DIFFERENTIAL EXPRESSION OF THE PRION GENE FAMILY IN GLIOBLASTOMA TUMORS. 87
Leber's Hereditary Optic Neuropathy (LHON)-related Mitochondrial DNA Sequence Changes in Italian Patients Presenting with Sporadic Bilateral Optic Neuritis. 87
Abbiategrasso brain bank protocol for collecting, processing and characterizing aging brains 87
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 87
Gene-environment interaction in parkinson's disease. The case of CYP2D6 polymorphism. 86
Late-onset myopathy after radiation therapy for thymoma in a young patient with myastenia gravis 86
Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. 86
Tumor infiltrating lymphocytes in early glioblastoma cell cultures 86
Migraine with aura and white matter abnormalities:Notch3 mutation. 85
Tissue autofluorescence potential for the intraoperative delineation of brain tumor resection margins. 85
Increase serum levels of cytokines and adhesion molecules in human tumor. 85
HLA class I antigen downregulation in brain tumours. 85
Structure of scrapie-associated protein and its relation to infectivity. 85
Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy 85
Optimizing separation efficiency of 2-DE procedures for visualization of different superoxide dismutase forms in a cellular model of amyotrophic lateral sclerosis 85
Studio di polimorfismi dei geni RAGE, TNF e recettori (TNFR1 e TNFR2) in pazienti con Sclerosi Laterale Amiotrofica (SLA). 84
Downregulation of HLA antigens and tumor malignancy in human gliomas 84
Modified expression of antioxidant enzymes in lymphocytes of sporadic amyotrophic lateral sclerosis patients 84
Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading 84
Totale 10.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.382 0 0 0 0 0 317 8 277 104 310 277 89
2021/20221.120 16 9 28 13 12 28 31 51 65 14 203 650
2022/20234.121 467 289 61 313 474 443 2 201 1.673 34 109 55
2023/20241.427 166 253 33 134 152 350 53 113 8 44 34 87
2024/20253.437 70 324 101 139 74 127 127 268 806 79 339 983
2025/20264.287 629 669 889 793 914 393 0 0 0 0 0 0
Totale 22.319